新活素在慢性肺源性心脏病伴心力衰竭治疗中的效果观察OA

Objective:Explore the therapeutic value of Xinhuosu in chronic pulmonary heart disease with heart failure.Method:A total of 70 patients with chronic pulmonary heart disease and heart failure who addmitted to Longyan Second Hospital from April 2022 to April 2025 were selected as the research subjects.The patients were divided into two groups through a lottery method.The control group(35 cases)received the standard treatment,while the intervention group(35 cases)received the standard treatment combined with Xinhuosi.Both groups were continuously intervened for 7 days.The comparison was made between the two groups in terms of cardiac function,pulmonary artery pressure and activity endurance.Result:Analysis of the differences in initial B-type natriuretic peptide(BNP),left ventricular ejection fraction(LVEF),and cardiac output(CO)between the two groups revealed no statistically significant differences(P＞0.05).After completing the 7-day therapy,compared to admission tests,BNP levels decreased in both groups,with the intervention group being lower than the conventional group.Both LVEF and CO were significantly higher,with the intervention group significantly higher than the conventional group,indicating statistically significant differences(P＜0.05).A comparative analysis of pulmonary artery systolic pressure and mean pressure at admission between the two groups showed no significant differences(P＞0.05).After implementing the intervention for 7 days,compared to admission,pulmonary artery pressure measurements decreased in both groups,with the intervention group being lower than the conventional group,indicating statistically significant differences(P＜0.05).Analysis of activity tolerance levels at admission between the two groups showed no significant statistical differences(P＞0.05).After implementing the intervention for 7 days,both groups showed improvement in activity tolerance indicators compared to admission,with the intervention group being higher than the conventional group,indicating statistically significant differences(P＜0.05).Conclusion:Xinhuansu helps to improve the patient's cardiac function,pulmonary artery pressure and enhance their activity endurance.